Inflammation as a target for prostate cancer chemoprevention: pathological and laboratory rationale.
about
Epidural analgesia during open radical prostatectomy does not improve long-term cancer-related outcome: a retrospective study in patients with advanced prostate cancerLoss of Nkx3.1 expression in bacterial prostatitis: a potential link between inflammation and neoplasia.Vitamin D and cancer.Multiphoton microscopic imaging of esophagus during the early phase of tumor progression.Acute bacterial inflammation of the mouse prostate.Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO studyCurrent and future status of prostate cancer chemoprevention.Evidence supporting the hypothesis that one of the main functions of the aryl hydrocarbon receptor is mediation of cell stress responses.Association of nonsteroidal anti-inflammatory drugs, prostate specific antigen and prostate volumeThe role of vitamin D in cancer prevention and treatment.The role of vitamin D in cancer prevention and treatment.Inflammatory and microenvironmental factors involved in breast cancer progression.The expression of vascular endothelial growth factor-C correlates with lymphatic microvessel density and lymph node metastasis in prostate carcinoma: An immunohistochemical studyBetulinic Acid-Mediated Apoptosis in Human Prostate Cancer Cells Involves p53 and Nuclear Factor-Kappa B (NF-κB) Pathways.Anti-proliferative properties of commercial Pelargonium sidoides tincture, with cell-cycle G0/G1 arrest and apoptosis in Jurkat leukaemia cells.Estrogen receptor α in cancer associated fibroblasts suppresses prostate cancer invasion via reducing CCL5, IL6 and macrophage infiltration in the tumor microenvironment.Intracellular EP2 prostanoid receptor promotes cancer-related phenotypes in PC3 cells.HMGB1: A Promising Therapeutic Target for Prostate Cancer.Vitamin K and its analogs: Potential avenues for prostate cancer management.A new proposed rodent model of chemically induced prostate carcinogenesis: distinct time-course prostate cancer progression in the dorsolateral and ventral lobes.The Prostate Cancer Patient Had Higher C-Reactive Protein Than BPH Patient.C-reactive protein is significantly associated with prostate-specific antigen and metastatic disease in prostate cancer.Exploring the anti-proliferative activity of Pelargonium sidoides DC with in silico target identification and network pharmacology.Role of the TNF-α receptor type 1 on prostate carcinogenesis in knockout mice.
P2860
Q28535425-49578817-505C-43DA-B498-B53A55A5AC63Q33816335-28395083-8228-45D5-A886-943D9DB16BE5Q34278228-167E125C-0E19-45C6-98B1-38EC4A5A34ACQ34593810-D282DFCF-929F-42DA-A36C-4C5D55487698Q35661399-A643EA80-36B5-4B3D-983D-CE7CD2BFD17EQ36075269-2FBD9ACB-17AB-4C7C-9306-9AB6DB060AE0Q36352079-6EE96B36-FEC4-4A88-89C0-B6D5468F3851Q36593646-166AE8C7-26E9-4996-8070-B75776A1FF6FQ37185428-AE9303D6-66B5-49AC-8867-7410A20F4823Q37761548-879FF4DB-D13C-4178-B49E-36807FF0AEF2Q38004753-415937F4-27A5-47E6-A1CA-32F26D5EE2F8Q38162168-E08DEFF0-9BCF-4AF9-9CE7-011188CE983DQ38390509-71D2C5F6-35F3-418A-9C2F-85F9F358DAD2Q38716171-DA7C51AF-04E6-4058-9CAA-5160D55D267AQ38801080-66937275-8C7A-4019-AFF9-A001044EEF1CQ38801346-651A97AC-7EBF-4AF2-8F7F-DC89035BA54FQ38892383-F6D996C7-EFB1-4638-825C-94A14DE6A25BQ41136849-2F256F1F-90DD-4105-B3D1-C4A35F8CBB75Q41339709-5EC869DD-F85D-4DC5-A5DF-AB5C3F4E5F59Q42437736-4655B3F5-56EE-4208-9E87-7C78941F81A7Q43241453-E4663177-1833-41FA-9376-9DB765946297Q45230840-8F0827E9-2550-42B6-90DD-B0C88AD29ED5Q47769226-B69416F5-51FF-4D6B-879A-9000DFD4746BQ53204207-76C8E68B-002C-467D-8198-84D4D0FD3665
P2860
Inflammation as a target for prostate cancer chemoprevention: pathological and laboratory rationale.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Inflammation as a target for p ...... ical and laboratory rationale.
@ast
Inflammation as a target for p ...... ical and laboratory rationale.
@en
type
label
Inflammation as a target for p ...... ical and laboratory rationale.
@ast
Inflammation as a target for p ...... ical and laboratory rationale.
@en
prefLabel
Inflammation as a target for p ...... ical and laboratory rationale.
@ast
Inflammation as a target for p ...... ical and laboratory rationale.
@en
P1476
Inflammation as a target for p ...... ical and laboratory rationale.
@en
P2093
Kathleen C Torkko
M Scott Lucia
P304
S30-4; discussion S35
P356
10.1097/01.JU.0000108142.53241.47
P407
P433
P577
2004-02-01T00:00:00Z